Lars Gullestad

27.6k citations
462 papers · 17.3k · 3 hit papers · h-index 65

Impact in

Papers in

    • Cardiovascular Function and Risk Factors 63
    • Heart Failure Treatment and Management 57
    • Viral Infections and Immunology Research 50
    • Cardiac Fibrosis and Remodeling 46
    • Transplantation: Methods and Outcomes 104

Lars Gullestad

449 papers receiving 17.0k citations

Lars Gullestad's Hit Papers

Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial 2016 · 271 citations
2710+4+8Years since publication100200300400500

Peers

Lars Gullestad
Comparison fields: 5 of 164
  • Cardiology and Cardiovascular Medicine 8.5k
  • Transplantation 789
  • Immunology 3.1k
  • Complementary and alternative medicine 840
  • Surgery 4.2k
Replace Ton J. Rabelink with:
Ton J. Rabelink Netherlands
Hermann Haller Germany
Douglas E. Vaughan United States
Juan J. Badimón United States
Ariela Benigni Italy
Howard J. Eisen United States
François Mach Switzerland
Pål Aukrust Norway
P. Christian Schulze Germany
Javier Dı́ez Spain
Lars Gullestad relative to Ton J. Rabelink Netherlands Ton J. Rabelink's profile →
Citations per field
00.5×1.5×2.3×
Ton J. Rabelink · 1×
Citations per year

Countries citing papers authored by Lars Gullestad

Since Specialization
Citations

This map shows the geographic impact of Lars Gullestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Gullestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Gullestad more than expected).

Fields of papers citing papers by Lars Gullestad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Gullestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Gullestad. The network helps show where Lars Gullestad may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Gullestad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Gullestad Line = papers co-authored together Lars Gullestad links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 462 papers — load more, or switch the sort, to bring in the rest.

#Work
1
EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
Hit paper breakdown →
2013588
2 1999412
3 2007403
4 1999366
5 2014360
6 1998310
7 2010295
8
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
Hit paper breakdown →
2016288
9 2012277
10
Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial
Hit paper breakdown →
2016271
11 2001271
12 2006239
13 2009235
14 2005198
15 2010186
16 2013173
17 2009164
18 2004162
19 2006157
20 1997156

About Lars Gullestad

Lars Gullestad is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology, Immunology and Oncology, having authored 462 papers that have together received 17.3k indexed citations. Recurring topics across this work include Transplantation: Methods and Outcomes (104 papers), Cardiovascular Function and Risk Factors (63 papers), Heart Failure Treatment and Management (57 papers), Viral Infections and Immunology Research (50 papers), Cardiac Fibrosis and Remodeling (46 papers), Atherosclerosis and Cardiovascular Diseases (39 papers), Renal Transplantation Outcomes and Treatments (37 papers) and Mechanical Circulatory Support Devices (33 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.5k citations), Transplantation (789 citations), Immunology (3.1k citations), Complementary and alternative medicine (840 citations) and Surgery (4.2k citations). Lars Gullestad has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Thor Ueland, Pål Aukrust, Arne Yndestad, Stig S. Frøland, Pål Aukrust, Jan Kristian Damås, John Kjekshus, Svein Simonsen, Erik Øie and Bente Halvorsen. Their work appears in journals such as The Journal of Heart and Lung Transplantation, Circulation, European Journal of Heart Failure, European Heart Journal and Clinical Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact